Seismology

Jason Keever Named President of Tax.com™, Ryan’s Innovative Software Solutions Division

Retrieved on: 
Monday, January 8, 2024

Ryan , a leading global tax services and software provider, has announced Jason Keever as the new President of Ryan’s tax.com™ division .

Key Points: 
  • Ryan , a leading global tax services and software provider, has announced Jason Keever as the new President of Ryan’s tax.com™ division .
  • Jason joins Ryan with more than 15 years of experience driving revenue at private equity-backed, high-growth software as a service (SaaS) companies.
  • “Ryan’s commitment to streamlining business and tax processes with advanced technology well aligns with my vision for implementing cutting-edge design and development capabilities,” said Jason.
  • “I look forward to making the tax.com™ brand the future of business tax technology.”
    In December of 2022, Ryan launched its innovative suite of tax.com™ technology solutions to manage compliance issues and create efficiencies for clients.

Seeing the human in every patient − from biblical texts to 21st century relational medicine

Retrieved on: 
Thursday, January 4, 2024

One study even called the care delivered to many vulnerable patients “inhumane.” Seismic changes caused by the COVID-19 pandemic – particularly the shift to telehealth – only exacerbated that feeling.

Key Points: 
  • One study even called the care delivered to many vulnerable patients “inhumane.” Seismic changes caused by the COVID-19 pandemic – particularly the shift to telehealth – only exacerbated that feeling.
  • In response, many health systems now emphasize “relational medicine”: care that purports to center on the patient as a human being.
  • Seeing each person before you as someone of infinite value is fundamental to many faiths’ beliefs about medical ethics.

Divine dignity

  • For doctors today, this might mean taking care not to inflict shame on a person with a stigmatized illness like substance use or obesity.
  • A 1981 Islamic code of medical ethics, for instance, considers the patient the leader of the medical team.
  • The doctor exists “for the sake of the patient … not the other way round,” it reminds practitioners.

Seeing and hearing the whole patient


In undergraduate classes that I teach for future health professionals at the University of Pittsburgh, we focus on communication skills to foster dignified care, such as setting a shared agenda with a patient to align their goals and the provider’s. Students also read “Compassionomics,” by medical researchers Stephen Trzeciak and Anthony Mazzarelli, which aggregates the data showing caring’s impact on the well-being of patients and providers alike.

  • However, even health professionals steeped in these practices can encounter people whose humanity they struggle to see.
  • The course evaluation is based on a project in which students interview a friend, relative or neighbor about their experience of illness and care.
  • Ultimately, they identify one element of the person’s care that could have been improved by attending more to the person’s individual needs and listening to their story.

Listening with both ears

  • Down the road at Chatham University, I work with physician assistant students who are about to enter clinic for the first time.
  • These students complete a workshop including many of the same communication exercises, including “listening with both ears”: listening not only to the patient, but also to what they themselves say to the patient, considering how it will be received.
  • Many of them report using patient-centered skills in challenging situations, such as validating patients’ concerns that had previously been dismissed.
  • Yet they also report a work culture where effective communication is often seen as taking too much time or as a low priority.
  • The emphasis on technology and a rapid pace of treatment leaves scant room for caring, whether in Heschel’s day or ours.


Jonathan Weinkle is affiliated with American College of Physicians and American Academy of Pediatrics.

Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock

Retrieved on: 
Monday, December 18, 2023

WARRINGTON, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for critical cardiovascular disorders, today announced that the Company recently enrolled the first subject in its Phase 2 SEISMiC Extension Study of istaroxime in the treatment of early cardiogenic shock. Study results are expected in mid-2024.

Key Points: 
  • The study of hospitalized patients with early cardiogenic shock (SCAI Stage B) due to acute heart failure (AHF) will evaluate two dose regimens of istaroxime compared to placebo.
  • In the previous SEISMiC study in early cardiogenic shock, patients were infused with drug or placebo for 24 hours.
  • The Company is also progressing the start-up of a parallel study in more severe, SCAI Stage C cardiogenic shock patients.
  • The istaroxime cardiogenic shock SCAI Stage C study is expected to enroll up to 20 subjects with SCAI Stage C cardiogenic shock due to AHF.

Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates

Retrieved on: 
Thursday, November 9, 2023

WARRINGTON, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today reported financial results for the third quarter ended September 30, 2023 and provided key business updates.

Key Points: 
  • WARRINGTON, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today reported financial results for the third quarter ended September 30, 2023 and provided key business updates.
  • “During the third quarter, we initiated our plan to move the istaroxime program in cardiogenic shock to Phase 3 readiness by advancing two clinical trials.
  • Research and development expenses were $2.1 million for the third quarter of 2023, compared to $1.5 million for the third quarter of 2022.
  • General and administrative expenses for the third quarter of 2023 were $2.6 million, compared to $2.7 million for the third quarter of 2022.

Seismic Appoints Russell Webb as Senior VP of International Sales and Customer Success

Retrieved on: 
Thursday, December 14, 2023

Seismic , the global leader in enablement, announced today that Russell Webb has joined as Senior Vice President of International Sales and Customer Success.

Key Points: 
  • Seismic , the global leader in enablement, announced today that Russell Webb has joined as Senior Vice President of International Sales and Customer Success.
  • With a track record in accelerating growth for international tech firms, Russell will oversee Seismic’s international business and lead its continued expansion in Europe and Asia-Pacific regions.
  • The appointment follows the company’s recent growth outside of its HQ in North America, with double-digit revenue growth year-over-year in international markets.
  • “I’m pleased to add Russell to our international roster and continue our investment in Europe and Asia-Pacific markets,” said Doug Winter, co-founder and CEO of Seismic.

Seismic Therapeutic Closes $121 Million Series B Financing to Advance Immunology Pipeline Optimized by its Machine Learning Platform

Retrieved on: 
Monday, December 4, 2023

Seismic Therapeutic, Inc ., the machine learning immunology company, today announced that it has closed a $121 million Series B financing.

Key Points: 
  • Seismic Therapeutic, Inc ., the machine learning immunology company, today announced that it has closed a $121 million Series B financing.
  • In addition, the Series B will enable the continued growth of the company’s pipeline in both the IgSc and DcB product areas, beyond the lead programs.
  • This progress resulted from Seismic’s integration of leading-edge machine learning into drug development in a specific area – biologics for immunology – powered by a diverse team of drug developers and machine learning innovators.
  • “This financing enables us to continue our momentum and advance both of our exciting lead programs into the clinic.

Golden State Cider Claims Top Spot in California and Showcases Mighty Dry as Nation's Leading Regional Cider

Retrieved on: 
Thursday, December 14, 2023

HEALDSBURG, Calif., Dec. 14, 2023 /PRNewswire/ -- Golden State Cider proudly announces its esteemed position as California's No. 1 cider brand1, showcasing a significant growth trajectory and an unwavering commitment to quality. The brand's flagship product, Mighty Dry, has notably achieved the status of the top regional cider SKU in the country, marking an 18 percent increase in sales2.

Key Points: 
  • Golden State Cider, celebrated for its quality-driven dry cider selections, announces this milestone while welcoming Seismic Brewing Company to its taproom in Sebastopol, California.
  • Among these are popular choices like Mighty Dry, Gingergrass, Brut, Jamaica, Mellow Hops, and the latest addition, Dry & Mighty.
  • Golden State Cider's rise to the top spot in California, along with Mighty Dry's distinction as the nation's leading regional cider, marks a significant achievement in the rich cider-making heritage of the West Coast.
  • "Bringing Golden State Cider and Seismic Brewing Co. together in this taproom venture is about more than just combining great cider and beer.

Seismic Fall 2023 Release leads with new generative AI capabilities to unlock growth and boost productivity

Retrieved on: 
Tuesday, October 24, 2023

Seismic , the global leader in enablement, today announced its Fall 2023 Product Release which brings several new generative AI-powered capabilities to the Seismic Enablement Cloud, including two major innovations in Aura Copilot and Seismic for Meetings.

Key Points: 
  • Seismic , the global leader in enablement, today announced its Fall 2023 Product Release which brings several new generative AI-powered capabilities to the Seismic Enablement Cloud, including two major innovations in Aura Copilot and Seismic for Meetings.
  • Seismic customers, as well as the wider enablement industry, have demonstrated a strong interest in applying AI to their go-to-market (GTM) processes.
  • “Our new offering of Aura Copilot packages AI insights, use cases, workflows, and capabilities to enable our customers to grow and win more business.
  • For more on Seismic’s AI innovation and our full statement on AI security and privacy, click here .

Seismic Introduces Seismic for Meetings, Changing the Way Customer-Facing Teams Conduct Meetings

Retrieved on: 
Tuesday, October 24, 2023

Seismic for Meetings makes the entire go-to-market organization more efficient and effective, helping to decrease sales cycle length, increase pipeline, and close more deals:

Key Points: 
  • Seismic for Meetings makes the entire go-to-market organization more efficient and effective, helping to decrease sales cycle length, increase pipeline, and close more deals:
    For sales teams, Seismic for Meetings streamlines how reps prepare, present, and follow up on meetings right from where they already work – the Seismic Enablement Cloud™.
  • Seismic for Meetings simplifies the meeting prep process of gathering content, personalizing for the customer, collaborating with teammates, and more.
  • “Customer meetings will never be the same after Seismic for Meetings,” said Krish Mantripragada, Chief Product Officer, Seismic.
  • “We're excited to start using Seismic for Meetings to help boost the productivity of our GTM teams and increase engagement with our customers.

Seismic Releases The State of AI in Enablement: 2023 Report, Finds AI Supercharges GTM Efforts and Improves Customer Satisfaction, Despite Hurdles

Retrieved on: 
Thursday, October 19, 2023

Seismic , the global leader in enablement, today released the findings of The State of AI in Enablement: 2023 Report .

Key Points: 
  • Seismic , the global leader in enablement, today released the findings of The State of AI in Enablement: 2023 Report .
  • Among this group, leaders predict an average of 23% growth will be directly attributed to AI utilization over the next five years.
  • Over half (66%) of GTM leaders who have deployed AI tools report that they encountered initial hurdles before eventually realizing positive outcomes.
  • Seismic conducted The State of AI in Enablement survey online between September 2 and 17, 2023.